Skip to content

To study the effect of Bioavailable Turmeric Extract on Healthy Aging

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Bioavailable Turmeric Extract on Biological Aging in Healthy Adults - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096502
Enrollment
60
Registered
2025-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Bioavailable Turmeric extract: One capsule in the morning containing 100 mg of Turmeric extract complex for 60 days Intervention2: Bioavailable Turmeric extract: One capsule in the morn

Sponsors

Arjuna Natural Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Males or female participants aged 50 years to 70 years 2. No clinically diagnosed chronic diseases 3. Normal blood pressure (SBP less than than 140 mmHg, DBP less than 90 mmHg) 4. Normal fasting blood glucose (less than or equal to 100 mg/dL) 5. Normal lipid profile (Total cholesterol less than 200 mg/dL, LDL less than 150 mg/dL, HDL greater than 40 mg/dL, Triglycerides less than 150 mg/dL) 6. BMI 18.5 29.9 kg/m 7. Willingness to provide informed consent and comply with study procedures

Exclusion criteria

Exclusion criteria: 1. Clinically diagnosed conditions (hypertension, diabetes, cardiovascular disease, metabolic disorders) 2. Use of anti-inflammatory, antioxidant, or immune-modulating medications/supplements within 30 days before study enrolment 3. Major surgery or hospitalization in the past six months 4. Participation in another clinical trial within three months 5. Smoking or excessive alcohol consumption (greater than 2 standard drinks/day) 6. Any condition that may interfere with study compliance or data interpretation.

Design outcomes

Primary

MeasureTime frame
Mean change in inflammatory and oxidative stress biomarkersTimepoint: Baseline, Day 30, Day 60

Secondary

MeasureTime frame
Mean change in other metabolic and age-related biomarkersTimepoint: Baseline, Day 30, Day 60;Mean change in scores of the assessment questionnairesTimepoint: Baseline, Day 30, Day 60

Countries

India

Contacts

Public ContactDr Giby Abraham

Arjuna Natural Private Limited

drbinu@arjunanatural.com09447818432

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026